#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14882	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2208	657.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1401	1401	C	947	C	822	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27460	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3612	741.3	0	.	n	.	0	T695C	SNP	695	695	T	934	934	C	1035	C	937	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27460	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3612	741.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1576	1576	A	850	A,C	778,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27460	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3612	741.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2210	2210	C	852	C	749	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27460	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3612	741.3	1	SNP	n	A2045G	1	A2045G	SNP	2045	2045	A	2284	2284	G	924	G	812	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27460	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3612	741.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2836	2836	C	927	C,T,A	811,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	986	folP	852	852	100.0	folP.l15.c30.ctg.1	1607	59.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1100	1102	AGC	108;112;116	A;G;C	97;101;105	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2700	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3321	78.3	1	SNP	p	S91F	0	.	.	271	273	TCC	566	568	TCC	127;127;128	T;C;C	119;118;120	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2700	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3321	78.3	1	SNP	p	D95G	0	.	.	283	285	GAC	578	580	GAC	135;136;135	G;A;C	125;126;124	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2700	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3321	78.3	1	SNP	p	D95N	0	.	.	283	285	GAC	578	580	GAC	135;136;135	G;A;C	125;126;124	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	778	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1400	53.9	1	SNP	p	G45D	1	.	.	133	135	GAC	578	580	GAC	113;113;112	G;A;C	103;103;103	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	578	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1075	52.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2476	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2845	83.7	1	SNP	p	D86N	0	.	.	256	258	GAC	483	485	GAC	113;113;113	G;A;C	111;109;111	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2476	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2845	83.7	1	SNP	p	S87W	0	.	.	259	261	AGT	486	488	AGT	112;113;111	A;G;T	108;110;109	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2476	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2845	83.7	1	SNP	p	S87I	0	.	.	259	261	AGT	486	488	AGT	112;113;111	A;G;T	108;110;109	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2476	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2845	83.7	1	SNP	p	S87R	0	.	.	259	261	AGT	486	488	AGT	112;113;111	A;G;T	108;110;109	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2476	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2845	83.7	1	SNP	p	S88P	0	.	.	262	264	TCC	489	491	TCC	113;112;109	T;C;C	111;110;107	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1976	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2415	76.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1436	1438	GGC	55;55;55	G;G;C,T	51;51;50,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1326	1328	GCA	149;151;150	G;C;A	129;134;133	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1329	1331	ATC	142;142;141	A;T;C	127;127;126	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1341	1343	GTG	140;141;138	G;T,C;G	128;126,1;128	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1341	1343	GTG	140;141;138	G;T,C;G	128;126,1;128	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1845	1847	ACC	99;100;98	A;C;C	85;89;88	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1899	1901	GCG	91;91;92	G;C;G	89;90;89	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1899	1901	GCG	91;91;92	G;C;G	89;90;89	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2022	2024	GGC	79;77;74	G;G;C	67;66;63	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2031	2033	GGC	61;60;60	G;G;C	54;53;53	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2412	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2541	91.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2049	2051	CCG	48;45;45	C;C;G,C	44;42;38,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4600	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3067	145.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1544	1546	CTG	72;72;73	C;T;G	67;66;66	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1120	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1503	71.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	319	319	C	63	C	58	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	A26V	NONSYN	76	78	GCC	440	442	GTC	97;98;99	G;T;C	96;95;97	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	506	508	GGA	146;144;149	G;G;A	122;121;123	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	623	625	GCT	134;134;135	G;C;T	122;122;123	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	629	631	AGC	134;135;130	A;G;C	120;119;115	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	721	722	CG	116;111	C;G	102;100	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	724	726	CAG	111;111;109	C;A;G	99;101;98	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	728	730	AAA	117;120;121	A;A;A	104;105;107	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	A125T	NONSYN	373	375	GCT	737	739	ACT	125;126;119	A;C;T	108;112;104	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	N134S	NONSYN	400	402	AAT	764	766	AGT	100;99;106	A;G;T	88;89;93	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	E137K	NONSYN	409	411	GAA	773	775	AAA	104;104;103	A;A;A	96;96;96	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	791	793	GAA	115;115;116	G;A;A	106;105;106	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	815	817	GCA	111;111;112	G;C,T;A,G	102;101,1;100,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	923	925	CAA	196;196;197	C;A;A	162;161;163	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	N189S	NONSYN	565	567	AAC	929	931	AGC	199;196;195	A;G;C	162;160;160	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	M209I	NONSYN	625	627	ATG	989	991	ATC	159;158;163	A;T;C	137;134;139	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	0	.	p	.	0	E210fs	FSHIFT	628	628	G	992	992	G	163	G,T	139,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	1	SNP	p	G120K	1	.	.	358	360	AAG	721	723	CGG	116;111;111	C;G;G	102;100;100	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	1	SNP	p	D121N	0	.	.	361	363	GAC	724	727	CGC	111;109;117	C;G;C	99;98;103	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1672	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1554	104.5	1	SNP	p	A121D	1	.	.	361	363	GAC	724	727	CGC	111;109;117	C;G;C	99;98;103	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6444	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4717	133.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1792	1794	AAT	151;151;154	A;A;T	130;130;131	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	518	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1148	43.8	1	SNP	p	V57M	1	.	.	169	171	ATG	549	551	ATG	97;99;101	A;T;G	88;88;91	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
